Cargando…
FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
Approximately 30% of patients with newly diagnosed acute myeloid leukemia (AML) harbor mutations in the fms-like tyrosine kinase 3 (FLT3) gene. While the adverse prognostic impact of FLT3-ITD(mut) in AML has been clearly proven, the prognostic significance of FLT3-TKD(mut) remains speculative. Curre...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159924/ https://www.ncbi.nlm.nih.gov/pubmed/34045454 http://dx.doi.org/10.1038/s41408-021-00495-3 |